Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Cash from Operations (2016 - 2018)

Armata Pharmaceuticals' Cash from Operations history spans 6 years, with the latest figure at 3195000.0 for Q4 2018.

  • For Q4 2018, Cash from Operations fell 34.87% year-over-year to 3195000.0; the TTM value through Dec 2018 reached 10627000.0, down 15.61%, while the annual FY2024 figure was 37551000.0, 20.82% up from the prior year.
  • Cash from Operations for Q4 2018 was 3195000.0 at Armata Pharmaceuticals, down from 2020000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 593000.0 in Q3 2017 and bottomed at 3691000.0 in Q1 2014.
  • The 5-year median for Cash from Operations is 2931000.0 (2017), against an average of 2664823.53.
  • The largest annual shift saw Cash from Operations soared 81.06% in 2017 before it tumbled 240.64% in 2018.
  • A 5-year view of Cash from Operations shows it stood at 3200000.0 in 2014, then rose by 27.97% to 2305000.0 in 2015, then skyrocketed by 35.01% to 1498000.0 in 2016, then plummeted by 58.14% to 2369000.0 in 2017, then crashed by 34.87% to 3195000.0 in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Cash from Operations are 3195000.0 (Q4 2018), 2020000.0 (Q3 2018), and 1876000.0 (Q2 2018).